SK Biopharmaceuticals Co., Ltd. (KRX:326030)
South Korea · Delayed Price · Currency is KRW 102,300
-700 (-0.68%)
At close: Apr 24, 2026
SK Biopharmaceuticals Market Cap
SK Biopharmaceuticals has a market cap or net worth of 8.07 trillion as of April 24, 2026. Its market cap has increased by 2.18% in one year.
Market Cap
8.07T
Enterprise Value
7.82T
Revenue
706.74B
Ranking
n/a
PE Ratio
30.22
Stock Price
102,300.00
Market Cap Chart
Since July 2, 2020, SK Biopharmaceuticals's market cap has decreased from 9.95T to 8.07T, a decrease of -18.90%. That is a compound annual growth rate of -3.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2026 | 8.07T | -17.34% |
| Dec 30, 2025 | 9.76T | 12.15% |
| Dec 30, 2024 | 8.70T | 10.66% |
| Dec 28, 2023 | 7.86T | 39.25% |
| Dec 29, 2022 | 5.65T | -25.82% |
| Dec 30, 2021 | 7.61T | -42.49% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ALTEOGEN | 19.13T |
| Samsung Epis Holdings | 14.61T |
| HLB Co., Ltd. | 7.96T |
| LigaChem Biosciences | 7.34T |
| Peptron | 5.90T |
| Voronoi | 5.69T |
| OliX Pharmaceuticals | 3.51T |
| D&D Pharmatech | 3.49T |